National Cheng-Kung University Hospital — Tainan

Public research footprint of National Cheng-Kung University Hospital, compiled from the ClinicalTrials.gov public registry.

998

Registered studies

416

Active

215

Recruiting now

397

Completed

100

Stopped or withdrawn

Most-studied conditions

Non-small Cell Lung Cancer · Myelofibrosis · Non-Small Cell Lung Cancer (NSCLC) · HER2-positive Breast Cancer

Recently updated registry entries

NCT04613596 — Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase… (Recruiting)
NCT04589845 — Tumor-agnostic Precision Immuno-oncology and Somatic Targeting Rational for You… (Active Not Recruiting)
NCT07623161 — A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at National Cheng-Kung University Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.